Skip to main content
Caplight Logo









EpiPaws

EpiPaws

Private
Fort Lauderdale, FloridaHealthcare & Life Scienceshttps://epipaws.com/

Last Round

Seed

Mar 24, 2025

Total Funding Raised

$275,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EpiPaws is a biotechnology company that provides an epigenetic biomarker-based age test for dogs and cats, allowing pet owners to determine their pet's age and gain health insights.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Non-AI

Keywords

pet health testingepigenetic testingbiological age testpet longevityat-home pet testDNA methylationpet wellnesspreventative pet caredog health testcat health testDTC pet healthpet biohackingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EpiPaws Comparables

Compare EpiPaws with similar companies based on industry and business-model similarity.

EpiPaws comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProsperK9
86%
Omi Health
85%
Woofgenix Inc.
82%

EpiPaws Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 24, 2025
GrantJan 31, 2023

Key People

Founding team and executive leadership

Andria Beal

CEO Founder

Founding Team

David Kincaid

CTO, Fractional

Executive Team

Garrett Walz

Chief Operating Officer

Executive Team

EpiPaws Investors

Notable investors and investment history

EpiPaws investors
InvestorRounds
Active CapitalGrant
New World AngelsSeed
Purina (9 Square Ventures)Grant
Active CapitalGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 173% MoM, reaching 6.2K.

  • Dec 15, 2025

    Launched HealthScore, an at-home biological age test for pets.

EpiPaws Filings

Explore SEC and related filing metadata, where available.

EpiPaws filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EpiPaws's valuation, stock price, and market status.

Is EpiPaws a public or private company?

EpiPaws is a private company.

What is the current stock price of EpiPaws?

EpiPaws is a private company with no public stock price. No recent secondary market data is available.

How much is EpiPaws worth (valuation)?

Valuation information for EpiPaws is not publicly available.

Can I buy EpiPaws stock?

EpiPaws shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EpiPaws's last funding round?

EpiPaws's most recent funding round was Seed on July 22, 2025.

Who are the main investors in EpiPaws?

Key investors in EpiPaws include Active Capital, New World Angels, Purina (9 Square Ventures).

Will EpiPaws IPO soon?

No public IPO plans have been announced for EpiPaws.

How can I track EpiPaws secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EpiPaws's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFort Lauderdale, Florida
Employee Range10
Year Founded2022
Last FundingMar 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?